Prot# ARRAY-797-201: A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of 12 Weeks of Treatment with ARRY-371797 in Patients with Active A

Project: Research project

Project Details

StatusFinished
Effective start/end date3/11/09 → 3/10/12

Funding

  • Array BioPharma Incorporated (ARRAY-797-201)